Rationale and design of the open-label, prospective, randomized study of the efficacy of intravenous versus oral iron deficiency therapy in improving left ventricular systolic function in patients with myocardial infarction (OPERA-MI)
Aim. Iron has a protective effect on cardiomyocytes during hypoxia, while iron deficiency (ID) directly affects its function, disrupting mitochondrial respiration, reducing their contractility and relaxation. Some studies have shown that ID is a predictor of adverse outcomes in patients with acute...
Saved in:
| Main Authors: | D R Khastieva, M I Malkova, E B Zakirova, I I Zakirova, I H Valeeva, N R Khasanov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2022-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4961 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of intravenous iron supply in patients with heart failure with reduced ejection fraction – a literature review
by: Katarzyna Dąbek, et al.
Published: (2024-12-01) -
Intravenous iron therapy for heart failure and iron deficiency: An updated meta‐analysis of randomized clinical trials
by: Mushood Ahmed, et al.
Published: (2025-02-01) -
Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience
by: Nikolina Brkić, et al.
Published: (2024-01-01) -
Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01) -
The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Inderbir Padda, et al.
Published: (2024-12-01)